| HS Code | 870347 |
| Product Name | BOC-L-serine |
| Chemical Name | N-(tert-Butoxycarbonyl)-L-serine |
| Cas Number | 3262-72-4 |
| Molecular Formula | C8H15NO5 |
| Molecular Weight | 205.21 g/mol |
| Appearance | White crystalline powder |
| Purity | ≥98% |
| Melting Point | 117-120 °C |
| Specific Optical Rotation | [α]20/D -6.5° (c=5, H2O) |
| Solubility | Soluble in ethanol, methanol, DMF, DMSO; sparingly soluble in water |
| Storage Conditions | Store at 2-8 °C, sealed |
| Smiles | CC(C)(C)OC(=O)N[C@@H](CO)C(=O)O |
As an accredited BOC-L-serine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | BOC-L-serine is packaged in a sealed glass bottle with an airtight cap, supplied as 5 g of white crystalline powder. |
| Container Loading (20′ FCL) | A 20′ FCL container loaded with BOC-L-serine, securely packed in sealed drums, palletized, labeled, and stowed for safe transport. |
| Shipping | BOC-L-serine should be shipped at ambient temperature in a sealed, moisture-resistant container. Avoid exposure to excessive heat, direct sunlight, or humidity. Ensure compliance with local chemical transport regulations. Handle with standard laboratory precautions, and keep the packaging upright and undamaged during transit. |
| Storage | Store BOC-L-serine in a tightly sealed container at –20°C, protected from moisture, heat, and light. Keep the container dry and desiccated. Avoid repeated freeze-thaw cycles; warm it to room temperature before opening to prevent condensation. Under these conditions, the compound remains stable for extended periods. |
| Shelf Life | Store dry at 2–8°C, protected from light. Shelf life is typically 2–3 years when unopened and handled properly. |
In Boc-benzyl solid-phase peptide synthesis, BOC-L-serine is coupled as an N-terminal or internal amino acid without side-chain protection when the target sequence contains a serine residue at the chain terminus or when the free β-hydroxy group is reserved for post-chain assembly modification. The building block is typically prepared as a 0.4 M solution in anhydrous N,N-dimethylformamide containing 0.4 M N-hydroxybenzotriazole. Activation is carried out with 1.0 eq N,N'-diisopropylcarbodiimide relative to the free amino groups on methylbenzhydrylamine resin. Coupling proceeds at 25–30°C for 45–60 min, and the resin is then washed with dimethylformamide and dichloromethane. The absence of a β-hydroxy protecting group removes one HF or trifluoromethanesulfonic acid cleavage concern but imposes a narrower process window because the serine hydroxyl can participate in intermolecular O-acylation when the activated carboxyl species is present in excess or when the coupling time is extended beyond 2 h.
On-resin product loss is observed in sequences where BOC-L-serine is followed by a C-terminal proline or glycine residue. The free amine liberated by Boc removal can intramolecularly attack the benzyl ester or resin linker to form a diketopiperazine, releasing the peptide from the support. Pilot syntheses using 0.1 mmol scale automated synthesizers suppress this loss by shortening the neutralization step to 2×1 min with 5% diisopropylethylamine in dimethylformamide and proceeding directly to coupling. In GMP contexts, incoming raw material is controlled under ICH Q7; identity by infrared spectroscopy per Ph. Eur. 2.2.24, specific rotation by Ph. Eur. 2.2.7, and residual solvents by headspace GC per Ph. Eur. 2.4.24 or USP <467>. Related substances are determined by reversed-phase HPLC on a C18 column (250 mm × 4.6 mm, 5 µm) with UV detection at 214 nm.
Terminal products assembled from BOC-L-serine include peptide amides, peptide acids, and peptide chains with a free N-terminal serine after final Boc deprotection. The final cleavage cocktail for Boc/benzyl synthesis is typically hydrogen fluoride containing 5–10% anisole or trifluoromethanesulfonic acid with scavengers. The resulting free hydroxyl is then available for downstream conjugation or analytical characterization. This building block is not preferred for internal serine residues that require O-glycosylation after chain assembly because the unprotected hydroxyl may be capped by subsequent coupling cycles.
Solution-phase condensation of peptide fragments containing BOC-L-serine is carried out in anhydrous tetrahydrofuran or acetonitrile at -5°C to 0°C. The carboxy component is preactivated with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride and 1-hydroxybenzotriazole in a molar ratio of 1.0:1.0:1.1 relative to the carboxyl group. Preactivation is limited to 3–5 min before addition of the amine fragment because the free β-hydroxy group can compete with the incoming amine and form O-acylated byproducts. Published data for BOC-L-serine-specific activation half-lives under these conditions are limited, but carbodiimide-mediated couplings of unprotected β-hydroxy amino acid derivatives show increasing hydroxyl acyl migration when preactivation exceeds 20 min at temperatures above 4°C.
Workup follows an acid–base sequence: the cooled mixture is quenched with 1 M aqueous citric acid, extracted with ethyl acetate, washed with 5% sodium bicarbonate and brine, dried over anhydrous sodium sulfate, and concentrated in a rotary evaporator with bath temperature 35°C. Purification of the protected fragment is performed by silica gel flash chromatography with an ethyl acetate/hexane gradient from 30% to 60%. Residual solvent control after drying follows ICH Q3C; dichloromethane is limited to 600 ppm, acetonitrile to 410 ppm, N,N-dimethylformamide to 880 ppm, and tetrahydrofuran to 720 ppm in the dried fragment.
Terminal products are protected dipeptide and tripeptide fragments with a free or esterified C-terminus, used in subsequent fragment condensation to longer peptides. The aqueous workup must be performed without prolonged exposure of the organic phase to sodium bicarbonate because the BOC-L-serine free hydroxyl can be partially ionized and extracted into the aqueous phase at pH above 10. This operational boundary is most relevant for small protected fragments containing a free carboxyl group. Coupling with hindered aliphatic amines is sluggish, and yields below 70% are encountered when the tertiary base is loaded above 1.5 eq; in such cases, the mixed anhydride method with isobutyl chloroformate is an alternative.
Where phosphopeptide libraries are synthesized on aminomethyl polystyrene supports, the unprotected β-hydroxy group of BOC-L-serine becomes the site for direct on-resin phosphorylation. After incorporation of BOC-L-serine and removal of the N-terminal Boc group with 50% trifluoroacetic acid in dichloromethane, the free hydroxyl is phosphitylated with dibenzyl N,N-diisopropylphosphoramidite at 0.25 M in anhydrous acetonitrile, activated by 0.45 M 5-ethylthio-1H-tetrazole. The reagent-to-resin ratio is typically 5:1 to 10:1 relative to free hydroxyl. Double coupling for 30 min each achieves phosphite conversion above 95% as judged by microcleavage followed by LC-MS. Oxidation to the protected phosphoserine is conducted with 5.5 M tert-butyl hydroperoxide in decane at 25°C for 30 min.
Incomplete phosphitylation leads to deletion peptides that contain unmodified serine and co-elute with the desired phosphopeptide during preparative reversed-phase HPLC. To reduce this failure mode, the resin is washed with anhydrous acetonitrile before phosphitylation and the tetrazole solution is dried over activated molecular sieves. When the sequence contains two adjacent BOC-L-serine residues, the second phosphorylation is often slower; the phosphoramidite ratio is increased to 12:1 and the coupling time is extended to 2×45 min. Cleavage from the resin uses Reagent K composed of trifluoroacetic acid/thioanisole/phenol/water/ethanedithiol 82.5:5:5:5:2.5 (v/v) followed by precipitation in cold diethyl ether.
Regulated discovery batches qualify the chromatographic method under ICH Q2(R1). The mobile phase consists of water/acetonitrile with 0.1% trifluoroacetic acid; detection is performed by UV at 214 nm and by online electrospray mass spectrometry. Final phosphopeptides are characterized by MALDI-TOF and 31P NMR. Terminal products are mono-, di-, and tri-phosphoserine-containing peptides used in signal transduction research, kinase substrate profiling, and inhibitor screening. Because the resin-bound hydroxyl remains available only if the subsequent activation cycles do not use excess acylation agents, capping of the hydroxyl is verified by microcleavage after the phosphorylation cycle.
For bioconjugation and enzyme-substrate synthesis, BOC-L-serine is converted to the N-hydroxysuccinimide ester in anhydrous dioxane or dichloromethane. The process charges 1.00 eq BOC-L-serine, 1.05 eq N-hydroxysuccinimide, and 1.10 eq N,N'-dicyclohexylcarbodiimide at 0°C. The mixture is stirred for 2 h at 0°C and then 12 h at 20°C. Dicyclohexylurea is removed by filtration through a 0.45 µm PTFE membrane, and the filtrate is concentrated under reduced pressure at 25°C. The active ester is used promptly because hydrolysis of the N-hydroxysuccinimide ester proceeds when free water exceeds 0.5% w/w.
Residual dicyclohexylurea is monitored by 1H NMR; the crude active ester is released for subsequent conjugation when the DCU N-H resonance integration corresponds to <2% w/w. HPLC purity is determined on a C18 column (150 mm × 4.6 mm, 3 µm) with water/acetonitrile mobile phases containing 0.1% trifluoroacetic acid, and free BOC-L-serine is limited to <1.0%. For industrial bioconjugation raw materials, batch records follow ISO 9001 and residual solvents are controlled by USP <467>. The free β-hydroxy group in BOC-L-serine can undergo intramolecular β-lactone formation when a catalytic amount of 4-dimethylaminopyridine is present; therefore DMAP is omitted from this specific active ester synthesis. If pentafluorophenol is used instead of N-hydroxysuccinimide, the same avoidance of catalytic bases applies.
Terminal products include N-Boc-L-serine N-hydroxysuccinimide ester, p-nitrophenyl ester, and mixed carbonates used for covalent modification of amine-functionalized surfaces, dendrimers, solid-phase capture resins, and diagnostic probe precursors. The activated carbamate is stable in dry organic solvents at -20°C for short storage periods, but reanalysis by HPLC is required before use because slow ester hydrolysis can occur in humid environments.
Reduction of BOC-L-serine to N-Boc-L-serinol is a chiral-pool route to enantiopure β-amino alcohols used in protease inhibitor medicinal chemistry. The carboxyl group is first esterified with iodomethane in N,N-dimethylformamide containing 1.1 eq potassium bicarbonate at 20°C. The resulting methyl ester is isolated by ethyl acetate extraction and then treated with 2.5 eq sodium borohydride in tetrahydrofuran/ethanol at 0°C. Addition of 1.0 eq calcium chloride improves the selective reduction of the ester in the presence of the N-Boc carbamate. The reaction is quenched with 1 M hydrochloric acid, extracted into ethyl acetate, and concentrated to a colorless oil. When lithium aluminum hydride is used instead of sodium borohydride, the addition must be performed at -10°C and the workup requires careful sequestration with sodium sulfate decahydrate; the N-Boc group may be partially reduced under prolonged exposure.
Enantiomeric purity of N-Boc-L-serinol is confirmed by chiral HPLC on an amylose-based column with hexane/isopropanol gradient; the acceptance criterion for an advanced intermediate is typically ≥99.0% enantiomeric excess. Residual tetrahydrofuran is controlled under ICH Q3C and is dried to below 720 ppm. The product is stored under inert gas at 2–8°C to reduce oxidation of the primary alcohol. Terminal products include N-Boc-L-serinol, oxazolidines, sulfonamide inhibitors, and amino alcohol-derived ligands for asymmetric synthesis.
Scale-up of the sodium borohydride reduction in a 20 L jacketed reactor requires controlled dosing of the ester solution because the initial hydrogen evolution is exothermic. Published data for BOC-L-serine-specific reduction yields above 1 kg scale are limited; pilot campaigns in similar N-Boc amino acid reductions have noted yield losses when the internal temperature exceeded 25°C.
Activation of the β-hydroxy group in BOC-L-serine permits the introduction of dehydroalanine into peptide chains under mildly basic conditions. The hydroxyl is first converted to a p-toluenesulfonate ester using 1.0 eq BOC-L-serine, 1.2 eq p-toluenesulfonyl chloride, and 2.0 eq pyridine in dichloromethane at 0°C for 3 h. After aqueous workup with 1 M hydrochloric acid and sodium bicarbonate, the sulfonate ester is treated with 1.2 eq lithium chloride in N,N-dimethylformamide at 50°C to effect β-elimination. Triethylamine is then added to trap the liberated sulfonic acid. The N-Boc group remains intact, yielding N-Boc-dehydroalanine for solution-phase incorporation or subsequent Michael addition reactions.
The exocyclic vinyl protons of the dehydroalanine product are confirmed by 1H NMR at δ 5.5–5.8 and 6.3–6.5 ppm. Residual pyridine and dichloromethane are controlled by headspace GC according to USP <467>. For intermediates used in peptide modification, HPLC purity is measured on a C18 column with UV detection at 210 nm. The β-elimination route is incompatible with peptides bearing unprotected lysine side chains because the sulfonate ester can react with free amines, leading to branched byproducts. Published data for large-scale preparation of N-Boc-dehydroalanine from BOC-L-serine are limited to laboratory-scale syntheses, typically below 100 mmol.
Terminal products are dehydroalanine-containing peptides and synthetic probes used to study cysteine alkylation, enzyme active-site nucleophiles, and post-translational modifications. Because dehydroalanine is a Michael acceptor, the final intermediates are stored in the absence of thiols and secondary amines at -20°C to prevent spontaneous addition. This application segment is most relevant for medicinal chemistry route scouting and peptide tool compound synthesis rather than high-volume production.
Competitive BOC-L-serine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
N-Boc-L-serine, CAS 3262-72-4, is supplied as a white to off-white crystalline powder with molecular formula C8H15NO5 and molecular weight 205.21 g/mol. The substance is the Nα-tert-butoxycarbonyl derivative of L-serine, meaning that the α-amino function is blocked by an acid-labile carbamate while the β-hydroxymethyl side chain remains free. Commercial grades are commonly differentiated as standard laboratory reagent lots with HPLC purity not less than 98.5% and custom cGMP-grade lots with purity not less than 99.0%. Typical packaging for bulk lots is a sealed polyethylene liner inside a fibre drum, stored at 2–8 °C under nitrogen or dry argon. The free side-chain hydroxyl distinguishes BOC-L-serine from O-protected analogues such as Boc-L-serine(benzyl ether) and Boc-L-serine(tert-butyl ether), while the N-protecting group distinguishes it from Fmoc-L-serine, Cbz-L-serine, and unprotected L-serine. The acid-labile Boc group is stable to basic piperidine/DMF conditions used for Fmoc cleavage and is removed selectively with trifluoroacetic acid-containing cocktails; this orthogonality defines the principal synthetic role of the product in peptide chemistry.
Process-scale use begins with correction for assay on the supplied CoA. Because the compound is a free carboxylic acid, the molecular weight used for stoichiometric calculation is 205.21 g/mol, not the hydrate or salt molecular weight. Weighing is performed on a precision balance with draft shield; the powder is transferred under local exhaust or in a laminar-flow hood to minimize operator exposure and protect the solid from ambient moisture. The material is soluble in DMF, DMSO, dichloromethane, ethyl acetate, and tetrahydrofuran at typical peptide synthesis concentrations of 0.1–0.5 mol/L; dissolution in DMF at 25 °C is complete within 5–15 min under gentle magnetic stirring. Aqueous solubility is lower and pH-dependent because the carboxylic acid exists partly as the carboxylate at neutral pH; for analytical method development, the compound is dissolved in acetonitrile/water mixtures rather than water alone. The free hydroxyl participates in hydrogen bonding and can interact with polar resin surfaces, which is why loading onto hydrophobic chlorotrityl resins is often carried out with excess base rather than with aqueous buffers.
Release documents for BOC-L-serine typically include the following controls. Compendial general chapters are cited where applicable; for non-compendial parameters, vendor in-house methods are employed under ISO 9001:2015 change control. Values shown are common CoA release ranges for standard and cGMP lots, not universal limits for every manufacturer.
| Parameter | Typical release range or limit | Control method |
|---|---|---|
| Appearance | White to off-white crystalline powder | Visual inspection |
| HPLC purity | ≥ 98.5% standard grade; ≥ 99.0% cGMP grade | USP <621> |
| Enantiomeric purity | D-enantiomer ≤ 0.5% | Chiral HPLC |
| Specific rotation | −4.0° ± 1.0° (c=1.0, acetic acid, 20 °C) | USP <781> / EP <2.2.7> |
| Water content | ≤ 0.5% | Karl Fischer, USP <921> / EP <2.5.12> |
| Residue on ignition/sulfated ash | ≤ 0.1% | USP <281> / EP <2.4.14> |
| Residual solvents | Conforms to ICH Q3C; primary process solvent typically ≤ 500 ppm for class 3 solvents | HS-GC, USP <467> |
| Identification | IR spectrum matches reference spectrum; principal carbonyl bands at 1680–1700 cm−1 and 1710–1740 cm−1 | EP <2.2.24> |
| Elemental impurities | Controlled per ICH Q3D Option 1 when specified for regulated intermediates | ICP-MS |
Batch-to-batch variance in commercial lots is most commonly observed in residual solvent content and water content. Vendors reduce both by vacuum drying at 35–45 °C for 12–24 h before final packaging. Drying above 50 °C is avoided because the tert-butyl carbamate can undergo partial thermal elimination; pilot-plant dryers with jacket temperature control of ±2 °C and oil-sealed vacuum pumps below 10 mbar are the typical equipment configuration. HPLC purity is usually stable between lots, but chiral HPLC can reveal enantiomeric drift if the raw material originates from a non-fermentation route. For cGMP-grade peptides, vendors may request a full mass balance including assay, water, residual solvents, sulfated ash, and HPLC purity; the sum of assay and non-assay components should approach 99.5–101.0% for release.
In solid-phase peptide synthesis, BOC-L-serine is employed as a carboxy-activated monomer rather than as a free acid. A representative first amino acid loading onto 2-chlorotrityl chloride resin at substitution 0.3–0.5 mmol/g uses 2.5–3.0 equivalents of BOC-L-serine and 5–10 equivalents of DIPEA in dichloromethane or dichloromethane/DMF 9:1 v/v. The reaction is usually run in a glass solid-phase reactor with a course frit, internal diameter 20–50 mm, and a PTFE stopcock. After 2–4 h, remaining active chloride groups are capped with methanol or a small amino acid; washing sequences alternate between DMF and DCM with 10–15 mL of solvent per gram of resin. Coupling completion is monitored by Kaiser ninhydrin, with blue color absent when the N-terminus is fully protected. For challenging couplings, BOC-L-serine is preactivated as the HOBt ester using DIC and HOBt in DMF at 0–5 °C; the mixture is added to the resin after 3–5 min of preactivation. Reverse-phase HPLC at 210 nm is used to monitor crude peptide later because the Boc group has limited chromophore and detection relies mainly on the peptide backbone.
The free β-hydroxyl of BOC-L-serine does not normally require side-chain protection during standard solid-phase synthesis when the peptide is cleaved under acid and the hydroxyl is retained. However, prolonged carbodiimide activation in DMF can produce O-acylated impurities if the activation solution is held for more than 6–8 h at 20–25 °C before coupling. On a peptide synthesizer with UV monitoring, the O-acyl byproduct may appear as a front-running peak or as a peak with slightly lower retention time under acidic mobile phase. For this reason, BOC-L-serine is activated in small aliquots or charged directly as the free acid with in situ coupling reagents at 0–5 °C. In automated peptide synthesizers using 10–50 mL reaction vessels, the amino acid solution is introduced through a needle under nitrogen; the system is programmed with a minimum of 2 wash cycles after each coupling to remove unreacted HOBt and DIC. Coupling of BOC-L-serine to hindered amino groups may require double coupling or the use of PyBOP/HOBt/DIPEA in NMP at 25 °C for 2–6 h. Published data for this specific configuration is limited; vendor technical bulletins commonly recommend extended coupling rather than elevated temperature because of the risk of epimerization at the protected serine center.
Long-term storage limitations for BOC-L-serine are governed by moisture, temperature, and packaging integrity. The compound is not strongly hygroscopic in dry form, but open-dish exposure at 40 °C/75% RH increases water content to above 1.0% within 48 h and can reduce HPLC purity below 97.0% by slow deprotection and solid-state side reactions. Stability data from vendor reports for sealed polyethylene/aluminum/polyester laminate packaging show moisture content below 0.2% and HPLC purity above 98.0% after 24 months at 2–8 °C. At 25 °C, sealed lots are usually stable for 6–12 months, but the risk of clumping increases if the container is repeatedly opened in an uncontrolled environment. Storage areas with relative humidity above 60% are therefore not recommended unless the operator uses sealed transfer boxes and desiccant pouches.
The tertiary butyl carbamate is sensitive to strong acids. Accidental exposure to hydrogen chloride vapor or a TFA bottle in the same cabinet can deprotect the amino group prematurely; even small losses of the Boc group are detected as a new ninhydrin-positive spot on TLC. The release of tert-butyl cation during deprotection can generate isobutylene and dimethylcarbinol-type byproducts; these are volatile and are removed during peptide work-up. In a sealed container, excessive deprotection gas formation is not expected, but the product should not be stored in glass bottles with metal caps that can corrode under acid vapor. For regulated manufacturing, a dedicated segregated storage area with continuous temperature monitoring at 2–8 °C and relative humidity logging is typical. A standard operating procedure for dispensing requires that the container be opened for no more than 15 min and that the remaining material be resealed under nitrogen. Incoming QC should reject lots with water content above 0.5% or with visible caking that cannot be broken by light mechanical action.
The choice between BOC-L-serine and Fmoc-L-serine is based on deprotection orthogonality, not on peptide yield alone. BOC-L-serine carries an acid-labile Nα protecting group; Fmoc-L-serine carries a base-labile Nα protecting group. In a synthetic route where base-sensitive esters, lactones, or side-chain functionalities are present, Boc chemistry is preferred because the final global deprotection step can be performed with TFA rather than piperidine. Conversely, if the resin-bound peptide contains acid-sensitive glycosidic bonds or O-glycosylated serine residues, Fmoc-L-serine may be preferred. The two derivatives are not interchangeable without modifying the entire protection scheme.
BOC-L-serine is also differentiated from Cbz-L-serine. The latter is removed by hydrogenolysis over palladium, typically 10% Pd/C at 1 atm H2 in ethanol or methanol. This route is incompatible with peptides containing sulfur-containing amino acids that can poison the catalyst or underivatized double bonds that undergo reduction. BOC-L-serine avoids catalytic hydrogenolysis and is therefore suitable for Cbz-free routes that require acidic cleavage. Unprotected L-serine, by contrast, cannot be used directly as the free Nα amino acid in standard carbodiimide-mediated coupling without causing self-condensation and oligomer byproducts; the Boc group blocks the amino function and directs activation to the carboxyl group.
| Derivative | Nα removal condition | Stability profile | Typical use boundary |
|---|---|---|---|
| BOC-L-serine | 25–50% TFA in DCM or >95% TFA cleavage cocktail | Stable to piperidine/DMF; base-stable; acid-labile | Boc SPPS; solution-phase routes with base-sensitive groups |
| Fmoc-L-serine | 20% piperidine/DMF | Stable to TFA; base-labile | Fmoc SPPS; acid-sensitive peptides |
| Cbz-L-serine | H2, 10% Pd/C | Stable to acids and bases; removed by hydrogenolysis | Solution-phase routes free of catalyst poisons |
| L-serine | No removal step | Reactive amino group; requires temporary in situ protection | Only for controlled aqueous or enzymatic transformations |
In commercial peptide manufacturing, the shift from Fmoc-L-serine to BOC-L-serine requires revalidation of the deprotection step. A Boc synthesis often uses a TFA/DCM 25:75 v/v deblock for Nα removal during stepwise assembly, followed by final cleavage with TFA/H2O/triisopropylsilane 95:2.5:2.5 v/v/v. The free hydroxyl of BOC-L-serine remains unprotected and can be acylated by TFA-derived species if scavenger levels are insufficient. Accordingly, the cleavage cocktail contains water and triisopropylsilane as scavengers, and the temperature is maintained at 20–25 °C for 30 min to 2 h depending on resin loading. The resulting crude peptide is precipitated in cold methyl tert-butyl ether at −20 °C and washed to remove non-peptide byproducts. If BOC-L-serine is replaced by Fmoc-L-serine in an existing route, the piperidine deblock step must be re-qualified because unreacted Fmoc-AA has a different chromophore and can mask resin-bound aggregation.
Acid-mediated deprotection of BOC-L-serine proceeds by protonation of the carbamate carbonyl followed by cleavage of the tert-butyl moiety. The released tert-butyl cation is trapped by scavengers such as water, triisopropylsilane, or anisole; without trapping, the cation can alkylate electron-rich side chains or generate isobutylene. At 25 °C, deprotection in TFA/DCM 1:1 v/v is usually complete within 30–60 min for resin-bound peptide. In solution-phase reactions, the same transformation can require 60–120 min at 0–25 °C when the starting material is dissolved in dichloromethane or ethyl acetate. Higher TFA concentrations above 90% accelerate deprotection but increase the risk of O-trifluoroacetylation at the free serine hydroxyl; therefore 50% TFA in DCM is considered a typical upper limit for stepwise deprotection of BOC-L-serine-containing sequences.
The free β-hydroxyl can react with activated carboxyl species during prolonged coupling. O-Acylation of the side chain converts the hydroxyl to an ester, giving a protected intermediate that may be difficult to distinguish from the target sequence by mass alone. In reverse-phase HPLC, the O-acylated impurity often shows an increase in retention time because the ester is more hydrophobic than the free alcohol. This side reaction is minimized by avoiding DMAP-catalyzed esterification with the amino acid carboxyl group, by maintaining activation temperature below 5 °C, by limiting activation time to 10–15 min before addition to resin, and by using less nucleophilic bases such as DIPEA or N-methylmorpholine rather than pyridine. When the free hydroxyl is not desired for downstream modification, the starting material is switched to an O-protected derivative such as Boc-L-serine(benzyl ether) or Boc-L-serine(tert-butyl ether); this switch changes the deprotection design because the O-protecting group must be removed separately under conditions that do not compromise the peptide.
After Boc deprotection, the free Nα-amino group is present as the protonated ammonium salt if the reaction is quenched in acid. Before the next coupling step, the amine is neutralized with DIPEA or N-methylmorpholine in DMF or NMP. In automated peptide synthesizers, the neutralization step is programmed separately from deprotection to limit salt formation and to maintain a defined resin bed volume. Incomplete neutralization leads to slow coupling and generates deletion sequences that are difficult to remove by preparative HPLC. The free amine of serine is slightly less sterically hindered than those of branched amino acids, but the β-hydroxyl can form a hydrogen-bonded network with DMF and water, which can retain solvent in the resin. Careful drainage and washing with DCM after DMF washes reduce this effect. Residual water above 0.5% in the coupling solvent can hydrolyze activated carboxyl species and lower coupling efficiency; therefore DMF and NMP are pre-dried over activated molecular sieves and monitored by Karl Fischer analysis before use.
Process analytical technology controls for BOC-L-serine deprotection include inline UV monitoring of the TFA wash stream at 280 nm or 254 nm, where the released carbamate byproducts absorb weakly. The disappearance of the Boc singlet in 1H NMR at δ 1.42 ppm is a direct solution-phase confirmation. In solid-phase synthesis, a small sample of resin is removed and subjected to a Kais test; a negative test after deprotection indicates that the Boc group has been removed and the free amine is present. A negative test after coupling with BOC-L-serine confirms successful chain extension without unreacted amino groups. These qualitative checks are supplemented with HPLC-MS of the final crude peptide. Operational boundaries are explicit: BOC-L-serine should not be combined with TFA before intended deprotection, should not be stored in uncontrolled humidity above 60% RH, and should not be dried above 50 °C because the Boc group begins thermal elimination. The product is incompatible with strong acids, acid chlorides, and oxidizing agents, and it should be kept away from primary amines in the presence of carbodiimide coupling agents to avoid premature amidation.
